Table 3.

Primary diagnosis at study enrollment


Diagnosis

PCT-FFP, no. (%); n = 60

C-FFP, no. (%); n = 61
Cirrhosis   45 (75)   47 (77)  
Acute hepatitis   1 (2)   1 (2)  
Hepatocellular carcinoma   1 (2)   0 (0)  
Multisystem organ failure   0 (0)   1 (2)  
Warfarin reversal   2 (3)   1 (2)  
Other
 
11 (18)
 
11 (18)
 

Diagnosis

PCT-FFP, no. (%); n = 60

C-FFP, no. (%); n = 61
Cirrhosis   45 (75)   47 (77)  
Acute hepatitis   1 (2)   1 (2)  
Hepatocellular carcinoma   1 (2)   0 (0)  
Multisystem organ failure   0 (0)   1 (2)  
Warfarin reversal   2 (3)   1 (2)  
Other
 
11 (18)
 
11 (18)
 

or Create an Account

Close Modal
Close Modal